ArticleBiophysical journal2025
Lipopolysaccharide nanoparticles: A biomimetic platform to study bacterial surface.
Article in Biophysical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lipopolysaccharides (LPSs) are essential components of the outer membranes of gram-negative bacteria, playing a crucial role in antimicrobial resistance, virulence, and the host's immune response. Self-assembled particles displaying LPSs are essential for biophysical studies addressing the behavior of bacterial surfaces under specific biomimetic conditions. Styrene-maleic acid copolymers were employed to form LPS nanoparticles, either from extracted LPS or directly from purified outer membranes. These nanoparticles, derived from pathogenic O157:H7 or laboratory Escherichia coli strains, are well-defined in size and yield high-resolution nuclear magnetic resonance spectra. They have been successfully used to investigate molecular recognition by a human C-type lectin receptor of the immune system and interaction with polymyxin antibiotics using various biophysical methods. This study highlights the significance of LPS nanoparticles as bacterial surface mimetics and opens promising avenues for further research into LPS structure and interactions. The ability to generate well-defined LPS nanoparticles offers a powerful tool for studying the molecular mechanisms underlying bacterial pathogenesis and immune response.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.